COMPLEMENT THERAPEUTICS
Complement Therapeutics operates as a preclinical stage company. Complement Therapeutics develops a precision medicine diagnostic platform allowing it to stratify patients based on their complement-activation profile with the potential to enable both patient selection and serving as an efficacy biomarker in future clinical studies.
COMPLEMENT THERAPEUTICS
Social Links:
Industry:
Biotechnology Medical
Founded:
2020-01-01
Address:
London, England, United Kingdom
Country:
United Kingdom
Website Url:
http://www.complementtx.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
5.65 M USD
Similar Organizations
Accent Therapeutics
Accent Therapeutics is a biopharmaceutical company.
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Leap Therapeutics
Leap Therapeutics is a clinical-stage biopharmaceutical company.
Neumora Therapeutics
Neumora Therapeutics operates as a clinical-stage biotechnology company.
Werewolf Therapeutics
Werewolf Therapeutics operates as an oncology biotherapeutics company.
Current Advisors List
Current Employees Featured
Investors List
BioGeneration Ventures
BioGeneration Ventures investment in Seed Round - Complement Therapeutics
Forbion Capital Partners
Forbion Capital Partners investment in Seed Round - Complement Therapeutics
BioGeneration Ventures
BioGeneration Ventures investment in Seed Round - Complement Therapeutics
Forbion Capital Partners
Forbion Capital Partners investment in Seed Round - Complement Therapeutics
Official Site Inspections
http://www.complementtx.com
- Host name: 141.193.213.11
- IP address: 141.193.213.11
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Complement Therapeutics"
Our Team – Complement Therapeutics
Dennis has over 18 years of experience as a drug developer, holding positions of increasing responsibility at Millenium Pharmaceuticals, Shire Human Genetic Therapies, Stealth Biotherapeutics, and most recently …See details»
Complement Therapeutics Ltd raises EUR 5 Million Seed Financing …
Feb 23, 2022 For more information please contact: Complement Therapeutics Ltd Dr Rafiq Hasan, CEO Email: [email protected] Forbion and BGV Laura Asbjornsen Email: …See details»
Complement Therapeutics - LinkedIn
Complement Therapeutics | 4,723 followers on LinkedIn. Developing the next generation of complement medicines | Complement Therapeutics GmbH (CTx) is an early-stage biotechnology company focused ...See details»
Board of Directors – Complement Therapeutics
Daniela Couto is a Partner at BGV having joined the fund in 2015. Daniela is an experienced investor and entrepreneur who has lead successful transactions. Daniela serves on the board of four portfolio companies and …See details»
Complement Therapeutics - Crunchbase Company Profile & Funding
Feb 23, 2022 Complement Therapeutics operates as a preclinical stage company.Where is Complement Therapeutics's headquarters? Complement Therapeutics is located in London, …See details»
Complement Therapeutics | LinkedIn
Complement Therapeutics GmbH (CTx) is an early-stage biotechnology company focused on the research and development of novel therapeutics for complement-mediated diseases. The …See details»
Complement System – Complement Therapeutics
The complement system, also known as complement cascade, is a part of the immune system that enhances (complements) the ability of antibodies and phagocytic cells to clear microbes …See details»
Complement Therapeutics - Craft
Complement Therapeutics is a biotechnology company focused on the research and development of novel therapeutics for complement-mediated diseases. It develops a pipeline of factor H …See details»
Complement Therapeutics GmbH - life-sciences-germany.com
Complement Therapeutics GmbH (CTx) is a German headquartered early-stage biotechnology company focused on the research and development of novel therapeutics for complement- …See details»
News – Complement Therapeutics
Munich, Germany – 26th November 2024 - Complement Therapeutics GmbH (CTx), a preclinical stage biotechnology company developing novel therapeutics for...See details»
Complement Therapeutics 2025 Company Profile: Valuation
May 7, 2021 Information on valuation, funding, cap tables, investors, and executives for Complement Therapeutics. Use the PitchBook Platform to explore the full profile.See details»
Complement Therapeutics Ltd - Golden
Company attributes Industry Biology Technology Biotechnology Drug discovery Location United Kingdom Number of Employees (Ranges) 1 – 10 Email Address [email protected] …See details»
Complement Therapeutics Company Profile | Management and
Find contact information for Complement Therapeutics. Learn about their Research & Development, Business Services market share, competitors, and Complement Therapeutics's …See details»
Complement Therapeutics Information - RocketReach
Complement Therapeutics is a Biotechnology company located in DE with 33 employees. Find top employees, contact details and business statistics at RocketReach.See details»
Overview, News & Similar companies - ZoomInfo.com
Apr 17, 2023 View Complement Therapeutics (www.complementtx.com) location in Greater London, United Kingdom , revenue, industry and description. Find related and similar …See details»
Complement Therapeutics - Executive Bio, Top Executies, and …
Complement Therapeutics operates as a preclinical stage company. Complement Therapeutics develops a precision medicine diagnostic platform allowing it to stratify patients based on their …See details»
Complement Therapeutics Ltd. - life-sciences-usa.com
Complement Therapeutics GmbH (CTx) is a German headquartered early-stage biotechnology company focused on the research and development of novel therapeutics for complement- …See details»
Complement Therapeutics Org Chart + Executive Team
The org chart of Complement Therapeutics contains its 22 main executives like Rafiq Hasan, Dominic Moreland and Rachel Green.See details»
Complement Therapeutics - 2025 Company Profile & Team - Tracxn
Jun 23, 2025 Complement Therapeutics - Developer of gene therapies to treat retinal diseases. Raised a total funding of $84.8M over 3 rounds from 9 investors. Valued at £85M. Founded by …See details»
Complement Therapeutics: Revenue, Worth, Valuation
Organization Complement Therapeutics complementtx.com Location London , London , Industry BiotechSee details»